Sigvard Olofsson - Infectious Diseases

Author Information

Sigvard Olofsson is a distinguished researcher affiliated with the Department of Infectious Diseases at the Institute of Biomedicine, Sahlgrenska Academy at the University of Gothenburg in Sweden. His work primarily revolves around the field of infectious diseases, with a particular focus on viral infections and glycoproteomics.

Research Contributions

Dr. Sigvard Olofsson has made significant contributions to the field of infectious diseases, particularly in understanding the mechanisms of viral infections. His research spans various aspects of virology, including the study of glycoproteins in viruses such as Herpes Simplex Virus, Varicella Zoster Virus, and Human Cytomegalovirus. His work has explored viral glycosylation patterns, potential targets in viral envelope glycoproteins, and serological diagnostics for HSV infections. Additionally, he has investigated oseltamivir resistance in influenza A viruses and cytokine responses in tonsillitis.

Aliases

Sigvard Olofsson is also known by several aliases in academic publications, including S Olofsson and S. Olofsson.

Publication and Citation Metrics

Metric	Value
Total Citation Count	4137
h-index	36
Total Paper Count	121

Publications:

Recombinant Glycoprotein E of Varicella Zoster Virus Contains Glycan-Peptide Motifs That Modulate B Cell Epitopes into Discrete Immunological Signatures

DOI: 10.3390/ijms20040954

Year: 2019

Regulatory Mechanisms of the Mucin-Like Region on Herpes Simplex Virus during Cellular Attachment.

DOI: 10.1021/acschembio.9b00064

Year: 2019

Linear Multiepitope (Glyco)peptides for Type-Specific Serology of Herpes Simplex Virus (HSV) Infections.

DOI: 10.1021/acsinfecdis.7b00001

Year: 2017

Viral O-GalNAc pe potential target in v

DOI:

Year: 2016

Global Mapping of O-Glycosylation of Varicella Zoster Virus, Human Cytomegalovirus, and Epstein-Barr Virus*

DOI: 10.1074/jbc.M116.721746

Year: 2016

Viral O‐GalNAc peptide epitopes: a novel potential target in viral envelope glycoproteins

DOI: 10.1002/rmv.1859

Year: 2016

Published sequences do not support transfer of oseltamivir resistance mutations from avian to human influenza A virus strains

DOI: 10.1186/s12879-015-0860-9

Year: 2015

A Strategy for O-Glycoproteomics of Enveloped Viruses—the O-Glycoproteome of Herpes Simplex Virus Type 1

DOI: 10.1371/journal.ppat.1004784

Year: 2015

High Cytokine Levels in Tonsillitis Secretions Regardless of Presence of Beta-Hemolytic Streptococci.

DOI: 10.1089/jir.2014.0123

Year: 2015

Comparison of the FilmArray assay and in-house real-time PCR for detection of respiratory infection

DOI: 10.3109/00365548.2014.951681

Year: 2014

When Should You Seek Medical Attention?

What are the Symptoms of Hepatitis B?

What Are the Challenges in Treating Viral Infections?

What Research is Being Conducted on Apicoplasts?

Is There a Treatment?

What are Serological Tests?

Why is Prevalence Important?

What Can Be Done to Mitigate the Impact of Climate Change on Infectious Diseases?

How Can Hepatitis B be Prevented?

What is Epidemiology?

Partnered Content Networks

Relevant Topics